The contributions of nitric oxide (NO) and renal blood flow (RBF) were examined in ischemia-reperfusion injury in the rat kidney. The function of both kidneys was assessed by glomerular filtration rate (GFR), and fractional excretion of sodium (FENa), calculated before, during unilateral renal artery clamping (45 min), and following reperfusion (90 min). RBF was measured in the same model by ultrasonic flowmetry. Intrarenal NO levels were modulated by administration of S-nitroso-N-acetylpenicillamine (SNAP), L-arginine, acetylcholine, and the NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME). SNAP increased GFR from 0.20 ± 0.04 ml/min in control ischemic kidney to 0.38 ± 0.06 ml/min and reduced FENa from 19.3 ± 3.4 to 9.5 ± 1.8%. Similar results were observed when L-arginine was administered. Acetylcholine had no effect on GFR or FENa. RBF was fully restored within 60 min following reperfusion, with no change in the rate of recovery by L-arginine. L-NAME aggravated the ischemia-reperfusion injury, preventing full restoration of RBF, further reducing GFR and worsening FENa. In conclusion, ischemia-reperfusion injury ends in low intrarenal levels of NO. We propose that this low NO level results from damage to the endothelial receptor signal transduction process and is not due to impaired NO synthase activity or to changes in RBF.

Keywords:
Renal ischemia, Reperfusion, Nitric oxide, Renal blood flow, S-nitroso-N-acetylpenicillamine, L-Arginine, Acetylcholine, NG-nitro-L-arginine methyl ester
1.
Canavese C, Strattaand P, Vercellone A: The case for oxygen free radicals in the pathogenesis of ischemic acute renal failure. Nephron 1988;49:9–15.
2.
Arendshorst WJ, Finn WF, Gottschalk CW: Pathogenesis of acute renal failure following temporary renal ischemia in the rat. Circ Res 1975;37:558–568.
3.
Cristol JP, Thiemermann C, Mitchell A, Walder C, Vane JR: Support of renal blood flow after ischemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites. Br J Pharmacol 1993;109:188–194.
4.
Greene EL, Paller MS: Oxygen free radicals in acute renal failure. Miner Electrolyte Metab 1991;17:124–132.
5.
Lieberthal W, Wolf EF, Rennke HG, Valeri CR, Levinsky NG: Renal ischemia and reperfusion impair endothelium dependent vascular relaxation. Am J Physiol 1989;256:F894–F900.
6.
Bechmann S, Mundel P: Nitric oxide in the kidney: Synthesis, localization and function. Am J Kidney Dis 1994;24:112–129.
7.
Catell V, Cook HY: NO: Role in the physiology and pathophysiology of the glomerulus. Exp Nephrol 1993;1:265–280.
8.
Radermacher J, Klanke B, Schurek HJ, Stolte HF, Frölich C: Importance of NO/EDRF for glomerular and tubular function: Studies in the isolated perfused rat kidney. Kidney Int 1992;41:1549–1559.
9.
Stoos BA, Garcia NH, Gavin JL: Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol 1995;6:89–94.
10.
Troup C, Persson AE: Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol 1994;267:F606–F611.
11.
Wilcox CS, Welch WJ: TGF and nitric oxide: Effects of salt intake and salt-sensitive hypertension. Kidney Int 1996;55(suppl):9–13.
12.
Baylis C, Harton P, Engels K: Endothelial relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1990;1:875–881.
13.
Lahera V, Salom MG, Miranda-Guardiol AF, Moncada S, Romero JC: Effect of NG-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol 1991;261:F1033–F1037.
14.
Gabbai FB, Garcia GE, Blantz RC, De Nicola L: Role of nitric oxide in glomerular physiology and pathophysiology. Adv Nephrol Necker Hosp 1995;24:3–18.
15.
Chintala MS, Chiu PJS, Vemulapalli S, Watkins RW, Syberts EJ: Inhibition of EDRF aggravates ischemic acute renal failure in anesthetized rats. Naunyn Scmiedebergs Arch Pharmacol 1993;348:305–310.
16.
Rubanyi GM, Romero JC, Vanhoutte PM: Flow-induced release of endothelium derived relaxing factor. Am J Physiol 1986;250:H1145–H1149.
17.
Sela S, Shasha SM, Mashiach E, Haj M, Kristal B, Shkolnik T: Effect of oxygen tension on activity of antioxidant enzymes and on renal function of the post ischemic-reperfused rat kidney. Nephron 1993;63:199–206.
18.
Davidson WD, Sackner MA: Simplification of the anthrone method for determination of inulin in clearance studies. J Lab Clin Med 1963;62:351–356.
19.
Ferwana OS, Pirie SC: Unilateral renal ischemia in the rat: Effect of method of occlusion of the blood supply on function of ipsilateral and contralateral kidneys. Clin Sci 1987;73:11–17.
20.
Baylis C, Mitrukaand B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992;90:278–281.
21.
Bech JN, Nielsen CB, Pedersen EB: Effects of systemic NO synthesis inhibition on RPF, GFR, UNa and vasoactive hormones in healthy humans. Am J Physiol 1996;270:F845–F851.
22.
Hastie LE, Patton WF, Hechtman HB, Shepro D: Filamin redistribution in an endothelial cell reoxygenation injury model. Free Radic Biol Med 1997;22:955–966.
23.
Schramm L, Heidbreder E, Schmitt A, Kartenbender K, Zimmermann J, Ling H, Heidland A: Role of L-arginine-derived NO in ischemic acute renal failure in the rat. Renal Fail 1994;16:555–569.
24.
Yokoyama S, Korthuis RJ, Benoit JN: Hypoxia-reoxygenation impairs endothelium-dependent relaxation in isolated rat aorta. Am J Physiol 1996;270:R1126–R1131.
25.
Evora PR, Pearson PJ, Schaff HV: Impaired endothelium-dependent relaxation after coronary reperfusion injury: Evidence for G-protein dysfunction. Ann Thorac Surg 1994;57:1550–1556.
26.
Conger JD, Hammond WS: Renal vasculature and ischemic injury. Renal Fail 1992;14:307–310.
27.
Riley AL, Alexander EA, Migdal S, Levinsky NG: The effect of ischemia on renal blood flow in the dog. Kidney Int 1975;7:27–34.
28.
Galat JA, Robinson AV, Rhodes RS: Effect of hypoxia on renal flow. J Trauma 1988;28:955–961.
29.
Conger J, Robinette J, Villar A, Raij L, Shultz P: Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest 1995;96:631–638.
30.
Ciolino HP, Levine RL: Modification of proteins in endothelial cell death due to oxidative stress. Free Radic Biol Med 1997;22:1277–1282.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.